Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Expert Opinion on Drug Safety|April 16, 2020
An update on the safety of nivolumab for the treatment of advanced melanomaAnna M Czarnecka, Piotr Rutkowski
Journal of Aging Research|March 16, 2011
The role of the mitochondrial genome in ageing and carcinogenesisAnna M Czarnecka, Ewa Bartnik
Expert Review of Anticancer Therapy|August 13, 2023
Pembrolizumab for the adjuvant treatment of IIB or IIC melanomaPiotr Rutkowski, Anna M Czarnecka
Journal of Applied Genetics|January 21, 2006
Mitochondrial DNA mutations in human neoplasiaAnna M Czarnecka, Pawel Golik, Ewa Bartnik
Expert Review of Anticancer Therapy|July 29, 2014
The use of sunitinib in renal cell carcinoma: where are we now?Anna M Czarnecka, Cezary Szczylik, Brian Rini
Postepy Higieny I Medycyny Doswiadczalnej (Online)|December 28, 2016
Mechanisms of angiogenesis in neoplasiaAnna Antonina Sobocińska, Anna M Czarnecka, Cezary Szczylik
Cancers|November 14, 2023
The Role of Macrophages in Sarcoma Tumor Microenvironment and TreatmentAgnieszka E Zając, Anna M Czarnecka, Piotr Rutkowski
Cancer Biology & Therapy|July 25, 2006
Mitochondrial chaperones in cancer: from molecular biology to clinical diagnosticsAnna M Czarnecka, Claudia Campanella, Giovanni Zummo, et al.
Oncology Letters|November 4, 2017
Renin angiotensin system deregulation as renal cancer risk factorPaweł Sobczuk, Cezary Szczylik, Camillo Porta, et al.
International Journal of Oncology|April 2, 2016
Hormone signaling pathways as treatment targets in renal cell cancer (Review)Anna M Czarnecka, Magdalena Niedzwiedzka, Camillo Porta, et al.
Pageof 17